Comparative evaluation of the genetic safety of stevia and erythritol
Year: 2026
Type: article
Abstract: Stevia ( Stevia rebaudiana ) and erythritol are widely used non-nutritive sweeteners because of their low caloric content and favorable metabolic properties. However, their long-term cytogenetic and toxicological safety remains under investigation. Focusing on genetic safety, this comparative review critically summarizes current in vitro , in vivo , and clinical evidence regarding the cytotoxic, genotoxic, oxidative, reproductive, and cardiovascular effects of stevia and erythritol. Available data indicate that steviol glycosides possess antidiabetic, antioxidant, anti-inflammatory, and organ-protective activities without convincing evidence of mutagenicity, genotoxicity, or carcinogenicity at acceptable intake levels. Reported cytotoxic and pro-apoptotic effects were primarily observed in cancer cell models and therefore should not be interpreted as evidence of toxicity in normal tissues. Likewise, conventional genotoxicity studies demonstrate that erythritol does not induce chromosomal aberrations, micronucleus formation, or significant DNA damage under standard exposure conditions. However, recent experimental and clinical studies have raised concerns regarding potential associations between erythritol exposure and oxidative stress, platelet activation, inflammation, and cardiovascular risk, warranting further investigation. Overall, current evidence supports the cytogenetic safety of stevia and erythritol within established acceptable daily intake levels, although additional well-designed long-term mechanistic and clinical studies are required to clarify tissue-specific responses and the biological significance of emerging toxicological findings.
Source: Discover Food
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,590
OpenAlex ID: W7233615215
FWCI:
Cites:
Cited by:
Related to:
